Pill Identifier App

Clinical Trials Update: Sept. 11, 2007

-- Here are the latest clinical trials, courtesy of Thomson CenterWatch:


This study will include children who were exposed to the anticonvulsant drug valproate before birth, to investigate whether prenatal exposure increases the risk for autism spectrum disorders, depending on each child's genetic makeup. To participate, children must be 2 years or older.

The research site is in Boston, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat612.html.


Multiple Sclerosis

This study will evaluate an investigational drug for people with multiple sclerosis who have cognitive impairment. Participants will be required to visit the clinic approximately six times over three months. Candidates must be 18 to 64 with at least a 9th grade education and a diagnosis of MS (relapsing remitting or secondary progressive). Additional criteria apply.

The research site is in Sarasota, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.



To qualify for this study of melanoma, candidates must have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, ECOG performance status of less than two, measurable disease according to modified RECIST, and a life expectancy of greater than 12 weeks. Females may not be pregnant or nursing.

The research site is in Lincoln, Neb.

More information

Please see http://www.centerwatch.com/patient/studies/cat791.html.


Copyright 2007 CenterWatch. All rights reserved.

Posted: September 2007

View comments